Ligand validation:2XBM

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 2XBM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2XBM_SAH_A_268	40%	9%	0.241	0.955	2.38	2.04	13	8	0	0	100%	1
2XBM_SAH_B_268	39%	8%	0.249	0.958	2.62	1.97	14	7	0	0	100%	1
2XBM_SAH_D_266	30%	1%	0.269	0.936	5.34	3.39	12	10	0	0	100%	1
2XBM_SAH_C_266	29%	3%	0.278	0.936	3.29	3.05	10	8	0	0	100%	1
3P8Z_SAH_C_263	82%	32%	0.089	0.943	1.19	1.48	2	3	1	0	100%	1
8BCR_SAH_B_302	71%	28%	0.104	0.924	1.22	1.67	2	4	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.